American CryoStem Joins Alliance for Regenerative Medicine
February 08 2012 - 9:00AM
Marketwired
American CryoStem Corporation (OTCQB: CRYO), a commercial
developer, manufacturer and marketer of clinical products and
services involving adipose tissue and adipose derived adult stem
cells, announced its association with the Alliance for Regenerative
Medicine (ARM).
ARM is a Washington, DC-based non-profit organization that
promotes legislative, regulatory and reimbursement initiatives
necessary to facilitate access to life-giving advances in
regenerative medicine. American CryoStem's decision to join ARM was
based on the alignment of its ongoing mission to offer the highest
quality products and services to help accelerate the regenerative
medicine industry and ARM's support of policy efforts toward safe
and reliable cellular products.
Morrie Ruffin, Managing Director for the Alliance for
Regenerative Medicine, commented, "We are delighted to have
American CryoStem as part of the Alliance and look forward to
working together to advance the field of adipose-derived stem cells
for a variety of therapeutic applications."
ARM's membership is diverse, representing leading regenerative
medicine companies and investors, university-based and non-profit
research institutions, patient advocacy groups, pharmaceutical
companies engaged in regenerative medicine research and other
organizations supporting regenerative medicine. American CryoStem
has created and commercialized core proprietary products and
platforms for processing, storing and quality management of adipose
tissue and adipose derived adult stem cells that are broadly
relevant to ARM's membership.
"American CryoStem is committed to working with industry
organizations to develop cutting edge adipose tissue based
treatments and therapies. One unique component of our clinical
laboratory product and service suite is offering individuals the
opportunity to cryogenically store their younger, healthier adult
stem cells for their own future use in regenerative medicine,"
stated John Arnone, American CryoStem CEO. "We are pleased and
honored to work with the Alliance for Regenerative Medicine to
educate the public and regulators on the safe uses of adult stem
cells and their potential life changing applications."
In support of these goals, the Company recently launched ACS
Laboratories, thus expanding its clinical processing technology to
companies, institutions and medical professionals. ACS Laboratories
offers a wide range of adipose tissue specific services. Through
ACS laboratories patented ACSelerate™ cell culture media, a ten
product suite, American CryoStem can leverage its technology and
products to participate in a broad range of clinical application
opportunities.
About American CryoStem: American CryoStem
Corporation (OTCQB: CRYO) markets clinical processing products and
services for adipose (fat) tissue and adipose derived adult stem
cells. CRYO's clinical processing and preservation platform
supports the science and applications being discovered globally by
providing the highest quality, clinically processed cells and
assuring their sterility, viability and growth cap abilities, while
at the same time developing cutting edge application, therapies and
laboratory products and services for consumers and physicians.
The Private Securities Litigation Reform Act of 1995 provides a
"safe harbor" for forward-looking statements. Certain of the
statements contained herein, which are not historical facts, are
forward-looking statements with respect to events, the occurrence
of which involve risks and uncertainties. These forward-looking
statements may be impacted, either positively or negatively, by
various factors. Information concerning potential factors that
could affect the Company is detailed from time to time in the
Company's reports filed with the Securities and Exchange
Commission.
Add to Digg Bookmark with del.icio.us Add to Newsvine
For More Information, contact: Investor Relations American
CryoStem Corporation 188 East Bergen Place, Suite 204 Red Bank, NJ
07701 Phone: 732-747-1007 www.americancryostem.com
American Cryostem (CE) (USOTC:CRYO)
Historical Stock Chart
From Jun 2024 to Jul 2024
American Cryostem (CE) (USOTC:CRYO)
Historical Stock Chart
From Jul 2023 to Jul 2024